NCT04647149

Brief Summary

Time-restricted eating (TRE) is a dietary approach that aims to increase fasting time and decrease the eating window. Promising TRE effects on weight loss and some cardiometabolic risk factors have been reported. However, there is a lack of randomized clinical trials that directly investigate the effect of TRE at different times of the day (early vs. delayed) in individuals with overweight and obesity. The present study investigates the effects of 8 weeks of TRE performed at different moments of the day on body composition and cardiometabolic parameters in adults with overweight and obesity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 3, 2019

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 12, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 12, 2020

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

November 14, 2020

Completed
16 days until next milestone

First Posted

Study publicly available on registry

November 30, 2020

Completed
Last Updated

November 30, 2020

Status Verified

November 1, 2020

Enrollment Period

8 months

First QC Date

November 14, 2020

Last Update Submit

November 22, 2020

Conditions

Outcome Measures

Primary Outcomes (6)

  • Insulin resistance (indices)

    Including but not limited to Homeostatic Model Assessment for Insulin Resistance (HOMA-IR).

    Change from baseline. Measured at baseline and after 8 weeks.

  • Fasting insulin levels (µIU/mL)

    Measured by enzyme-Linked Immunosorbent Assay

    Change from baseline. Measured at baseline and after 8 weeks.

  • Fasting glucose levels (mg/dL)

    Measured by colorimetric method

    Change from baseline. Measured at baseline and after 8 weeks.

  • Insulin Sensitivity (indices)

    Including but not limited to the Matsuda index

    Change from baseline. Measured at baseline and after 8 weeks.

  • Glucose tolerance

    Measured by oral glucose tolerance test (OGTT; 0,30,60,90, and 120 min)

    Change from baseline. Measured at baseline and after 8 weeks.

  • Fasting lipid profile levels (mg/dL)

    Measured by colorimetric method

    Change from baseline. Measured at baseline and after 8 weeks.

Secondary Outcomes (15)

  • β cell function (indices)

    Change from baseline. Measured at baseline and after 8 weeks.

  • Fat Mass (kg)

    Change from baseline. Measured at baseline and after 8 weeks.

  • Fat Percentage (%)

    Change from baseline. Measured at baseline and after 8 weeks.

  • Fat Free Mass (kg)

    Change from baseline. Measured at baseline and after 8 weeks.

  • Body Weight (kg)

    Change from baseline. Measured at baseline and after 8 weeks.

  • +10 more secondary outcomes

Study Arms (3)

Early Time-Restricted Eating

EXPERIMENTAL

8-hour eating window between 08:00 and 16:00

Behavioral: Dietary Approach

Delayed Time-Restricted Eating

EXPERIMENTAL

8-hour eating window between 12:00 and 20:00

Behavioral: Dietary Approach

Control

EXPERIMENTAL

12-hour eating window between 08:00 and 20:00

Behavioral: Dietary Approach

Interventions

Dietary approaches with energy restriction performed at different times of the day.

ControlDelayed Time-Restricted EatingEarly Time-Restricted Eating

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male and female;
  • Body mass index (BMI) between 25 and 34.9 kg/m²;
  • Age between 20 and 40 years;
  • Not engaged in any structured exercise program;
  • Weight stable for \~3 months prior to the beginning of the study;
  • Able to give written informed consent.

You may not qualify if:

  • Current smoker;
  • Cardiometabolic diseases (dyslipidemia, diabetes, hypertension, etc);
  • Current treatment with medication or supplements which significantly affect the main studied variables;
  • Night-shift workers;
  • Night eating syndrome;
  • Irregular sleep patterns;
  • For women: pregnancy, planned pregnancy (within the study period), lactating or menopause;
  • Habitual fasting window \>16 hours;
  • Concomitant participation in other studies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidade Federal do Rio Grande do Sul

Porto Alegre, Rio Grande do Sul, 90690-200, Brazil

Location

MeSH Terms

Conditions

Intermittent FastingObesityOverweight

Condition Hierarchy (Ancestors)

FastingFeeding BehaviorBehaviorOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Alvaro Reischak-Oliveira

    Federal University of Rio Grande do Sul

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 14, 2020

First Posted

November 30, 2020

Study Start

September 3, 2019

Primary Completion

May 12, 2020

Study Completion

May 12, 2020

Last Updated

November 30, 2020

Record last verified: 2020-11

Locations